sur Bausch Health Companies Inc. (NASDAQ:BHC)
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
Bausch Health Companies Inc., along with its gastroenterology division Salix Pharmaceuticals, has announced the 2025 recipients of its Salix Gastrointestinal Health Scholars Program. Ten students with gastrointestinal diseases will each receive a $10,000 scholarship, marking the program's sixth year. The scholarship aims to support higher education for students facing GI conditions.
More than 370 applicants vied for the scholarship, submitting personal essays on how their conditions have influenced their educational journeys. Awards were given in categories including Undergraduate, Graduate, and Working and/or Single Parent Scholar Awards.
The initiative not only provides financial assistance but also acknowledges the resilience and determination of these students. Recipients like Alexis Weary and Samantha Smith expressed gratitude, highlighting how the scholarship supports their academic and professional aspirations.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bausch Health Companies Inc.